重药控股股份有限公司 2025年第一季度报告

Core Viewpoint - The company has announced its 2024 profit distribution plan, proposing a cash dividend of 0.3 RMB per 10 shares, which is subject to approval at the annual shareholders' meeting [17][18][19]. Financial Data Summary - The company reported a net profit of 206,514,122.67 RMB for the year 2024, with a total equity of 6,921,093,142.90 RMB as of December 31, 2024 [18][19]. - The total cash dividend amount is projected to be 51,845,540.88 RMB, which represents 36.64% of the company's net profit for the year [20][21]. Changes in Financial Indicators - The company’s cash dividend distribution plan is consistent with its past performance, as the cumulative cash dividends over the last three years have exceeded 30% of the average annual net profit [21]. - The company has maintained a reasonable cash dividend policy that aligns with its operational needs and shareholder returns [22]. Approval Process - The profit distribution plan was approved by the board of directors with unanimous support and is deemed to not adversely affect the company's operational cash flow [23][24]. - The supervisory board also approved the plan, confirming its compliance with legal regulations and the company's articles of association [24][25].